ACM
NUVB icon

Aisling Capital Management’s Nuvation Bio NUVB Stock Holding History

Aisling Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,960,659
Closed -$11M – 14
2025
Q3 		$11M Buy
2,960,659
+419,650
+17% +$1.14M 2.4% 4
2025
Q2 		$4.95M Hold
2,541,009
– – 1.38% 6
2025
Q1 		$4.47M Hold
2,541,009
– – 1.55% 6
2024
Q4 		$6.76M Hold
2,541,009
– – 2.4% 7
2024
Q3 		$5.82M Hold
2,541,009
– – 2.23% 8
2024
Q2 		$7.42M Hold
2,541,009
– – 3.21% 5
2024
Q1 		$9.25M Hold
2,541,009
– – 3.13% 7
2023
Q4 		$3.84M Hold
2,541,009
– – 1.14% 7
2023
Q3 		$3.4M Hold
2,541,009
– – 1.4% 8
2023
Q2 		$4.57M Hold
2,541,009
– – 2.24% 7
2023
Q1 		$4.22M Hold
2,541,009
– – 2.03% 8
2022
Q4 		$4.88M Hold
2,541,009
– – 3.22% 8
2022
Q3 		$5.69M Hold
2,541,009
– – 3.78% 7
2022
Q2 		$8.23M Hold
2,541,009
– – 5.87% 6
2022
Q1 		$13.4M Hold
2,541,009
– – 7.21% 5
2021
Q4 		$21.6M Hold
2,541,009
– – 7.62% 4
2021
Q3 		$25.3M Hold
2,541,009
– – 5.04% 3
2021
Q2 		$23.7M Hold
2,541,009
– – 3.79% 5
2021
Q1 		$26.6M Buy
+2,541,009
New +$28.4M 4.78% 3

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Aisling Capital Management's NUVB Position: Q4 2025 in Review

Aisling Capital Management sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 2,960,659 shares — an estimated $11M sold.

Aisling Capital Management first reported a position in NUVB in Q1 2021 and held it in 19 quarters. The position peaked at $26.6M in Q1 2021. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Aisling Capital Management reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
  • Aisling Capital Management sold 2,960,659 Nuvation Bio shares in Q4 2025, an estimated $11M.
  • Aisling Capital Management first reported a position in Nuvation Bio in Q1 2021 and held it in 19 quarters.
  • Aisling Capital Management's Nuvation Bio position peaked at $26.6M in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Aisling Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.